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Rinki Murphy1,3*, Deborah Mackay2 and Ed A Mitchell2Abstract
Background: Loss of methylation (LOM) at imprinting control region (ICR) 1 or LOM at ICR 2 on chromosome
11p15 in leucocyte DNA is commonly used to diagnose the imprinting disorders Silver Russell syndrome (SRS)
characterized by growth restriction or Beckwith Wiedemann syndrome (BWS) characterized by overgrowth,
respectively.
Case presentation: A child was normally conceived and born by caesarian section to a healthy 19 year old
smoking mother (G2P1) at 38 weeks gestation, with SGA (birthweight SDS −2.44), placenta weight 250g (normal
histology), with an umbilical hernia and transient neonatal hypoglycemia but no other features of BWS.
The methylation status at 11p15 region was initially investigated by multiplex ligation dependent probe
amplification (MLPA). Subsequently, methylation-specific (ms) PCR was performed to screen for this and other
imprinted loci abnormalities at PLAG1 (6q24), IGF2R (6q27), GRB10 (7p12), PEG1/MEST (7q32), DLK1 (14q32), SNRPN
(15q11); PEG3 (19q32), NESPAS/GNAS (20q13).
Leucocyte DNA methylation was normal at ICR1 but markedly reduced at ICR2 using both MLPA and ms-PCR, and
no other anomalies of imprinting were detected. Buccal DNA methylation was normal at all imprinted sites tested.
Conclusion: This is the first report of an isolated LOM at ICR2 in leucocyte but not buccal DNA in a normally
conceived singleton SGA child without overt SRS or BWS.
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Two clusters of imprinted genes critical to early human
growth are expressed in a parent of origin-specific man-
ner under the control of imprinting control regions
(ICR) on chromosome 11p15. These are CpG-rich
regions that are differentially methylated on the mater-
nally and paternally derived chromosomes (differentially
methylated regions or DMR). ICR1 (or H19 DMR) is
methylated on the paternally-inherited allele and regu-
lates expression of insulin-like growth factor 2 (IGF2)
and H19. ICR2 (or KvDMR) is methylated on the
maternally-inherited allele and regulates expression of* Correspondence: R.Murphy@auckland.ac.nz
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reproduction in any medium, provided the orcell cycle regulator CDKN1C [1]. Loss of methylation
(LOM) of ICR1 is a major cause of Silver Russell syn-
drome (SRS: OMIM 180860), characterized by intrauter-
ine and postnatal growth restriction and a variable
expression of limb asymmetry, relative macrocephaly,
triangular face and feeding difficulties in early childhood
[2,3]. LOM of ICR2 is a major cause of Beckwith Wiede-
mann syndrome (BWS: OMIM 130650), characterized
by fetal overgrowth and a variable expression of other
features such as macroglossia, abdominal wall defects
and predisposition to embryonal tumours [1].
Cases of SRS and BWS with hypomethylation at both
ICR1 and ICR2 have recently been described [4-6]. Fur-
thermore, apparently healthy monozygotic twins of
either SRS [2,4] or BWS [7] probands have been found
to have similar methylation defects as their affected
twins in leucocyte but not buccal DNA. Additional
hypomethylation at multiple imprinted loci outside ofl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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patients with BWS or SRS [5-7]. LOM at ICR2 as part of
multi-locus hypomethylation is also seen in leucocyte
DNA from a proportion of cases with transient neonatal
diabetes due to LOM of 6q24 [8,9]. Here we report a
singleton female patient born small for gestational age
(birthweight SDS −2.44) with isolated LOM at ICR2 in
leucocyte but not buccal DNA who had transient neo-
natal hypoglycemia and an umbilical hernia, but no
other features of BWS or SRS.Case presentation
We identified this case after screening leucocyte DNA
from 366 phenotypically normal children, who took part
in the ABC study [10], for methylation abnormalities in
ICR1 and ICR2, as part of our investigation into the role
of common epigenetic variation in determining risk of
low birthweight (manuscript under review).
The Caucasian female (46 XX) was conceived naturally
and born by Caesarean section to a 19 year old, ex-
smoking mother (BMI 21kg/m2), after a pregnancy com-
plicated by urinary tract infection in the first month, and
hyperemesis in the third trimester. There was no family
history of BWS. Birth weight was 2.19 kg at 38 weeks
gestation, 2.44 standard deviation score (SDS) below
the mean in normal subjects, and placental weight
250g (1.7 SDS below the mean in ABC study), with nor-
mal placental examination and histology. She had no
neonatal morbidity and no features of either SRS or
BWS, other than a small umbilical hernia and transient
neonatal hypoglycemia. Hypoglycemia (1.0mmol/L) wasFigure 1 Clinical presentation of the subject at the age of 13.5 years.detected 2 hours after birth, which was treated with two
infant formula feeds and blood glucose at 4 hours was
3.6mmol/L. Her postnatal intellectual development and
growth was normal, achieving height between the 25th
and 50th centile, weight between 50th and 75th centile at
13.5 years. Full examination by an experienced paediatri-
cian (EM) was entirely normal at this age, in particular
with no dysmorphic features, no hemihypertrophy, nor-
mal skin and ear creases (Figure 1). Chest X-ray, and
renal ultrasound appearances were normal at the age
of 13 years.Methods
We used DNA extracted from blood leucocytes using
Qiagen’s DNA extraction kit. The methylation status
at H19 and KvDMR was investigated by multiplex
ligation dependent probe amplification (MLPA) using the
SALSA MLPA ME030-B1 BWS/RSS kit (lot 0208) pur-
chased from MRC-Holland (Amsterdam, The Netherlands)
using the manufacturer’s instructions. In brief, approxi-
mately 100ng genomic DNA was first denatured and
hybridised overnight with the probe mixture supplied
with the kit, and then, after splitting the sample in
two, treated either with ligase alone or with ligase
and HhaI. PCR reactions were then performed with
the reagents and primers supplied in the kit. The
PCR products were separated on a 36cm capillary (model
3130XL, Applied Biosystems Foster City, CA, USA). The
electropherograms were analyzed using Genescan soft-
ware, and the relative peak area was calculated using
the Coffalyser version 9.4 software (MRC-Holland). The
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three SD from the mean normalized ratios, was con-
firmed using methylation-specific PCR using bisulphite
treated DNA as previously described [6], and further
interrogated with MS-PCR for imprinting abnormalities
at 8 other imprinted loci (PLAG1 (6q24), IGF2R (6q27),
GRB10 (7p12), PEG1/MEST (7q32), DLK1 (14q32),
SNRPN (15q11); PEG3 (19q32), NESPAS/GNAS (20q13)).Molecular genetic results
MLPA analysis of leucocyte derived DNA showed nor-
mal DNA methylation at ICR1 (H19 DMR) but marked
LOM at ICR2 (KvDMR) (Figure 2); Individual methyla-
tion values for the four probes in KvDMR was 9% at
7171-L6780, 10% at 6276-L5782, 26% at 7172-L6781 and
11% at 7173-L6782. Individual methylation values for
the four probes in H19DMR was 77% at 8743-L8763, 52%
at 8744-L8764, 66% at 11080-L11762, 41% at 6266-L5772.
LOM of ICR2 from leucocyte DNA but not buccal DNA
was confirmed using MS-PCR (Figure 3). Testing for
imprinting abnormalities at 8 other imprinted loci (PLAG1








































































































































Figure 2 Capillary electrophoresis pattern generated from the methy
Upper panel indicates the result from the digestion reaction in the proban
non-digested proband leucocyte sample. Dashed arrows indicate the four
four different CpG sites in the KvDMR. Greater than 50% signal reduction a
KvDMR but not at H19DMR.DLK1 (14q32), SNRPN (15q11); PEG3 (19q32), NESPAS/
GNAS (20q13) using MS-PCR was normal.Discussion
Our finding of LOM at ICR2 in leucocyte DNA but not
in buccal DNA in a normally conceived, healthy child
born small for gestational age is a novel observation
and is important for two main reasons: Firstly, detecting
a BWS epigenotype in blood but not buccal DNA in
a child without clinical features of either BWS or SRS
adds to the clinical spectrum of those found to have
LOM ICR2. Secondly, given we screened 366 healthy,
normally conceived children to find one case of LOM at
ICR2, the prevalence of this epimutation is rare in the
general population.
There are three possible explanations for our finding
of isolated LOM at ICR2 in blood but not buccal DNA
in an asymptomatic girl born SGA: (1) her result is part
of the epigenetic variation within ICR2 seen in the
normal population, including the 10% born SGA (2) she
is sufficiently mosaic for the BWS epigenotype that
































































































































































lation specific MLPA reaction using the BWS/RSS probemix.
d leucocyte sample, the lower panel indicates the result from the
different CpG sites in the H19DMR and the solid arrows indicate the












Figure 3 Electropherograms of methylation-specific PCR amplicons for imprinting control regions 1 and 2 (ICR1 and ICR2)
corresponding to H19 differentially methylated region (H19DMR). The amplicon is identified above the first column as KvDMR and H19DMR
above the second column, as are the methylated (me) and unmethylated (un) peaks corresponding to maternal (mat) or paternal (pat) origin
respectively. Top row result from control leucocyte sample, middle row from proband leucocyte sample and bottom row result from proband
buccal sample within the same experiment. Presence of both peaks at equivalent abundance to the normal control is consistent with a normal
methylation profile; reduction of the maternal peak height at KvDMR indicates relative hypomethylation at this site as seen in the proband
leucocyte DNA.
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a true BWS case.
Epigenetic variation at ICR2 in the general population
has not been well described. Our molecular genetic
result may simply represent a rare finding of LOM of
ICR2 in blood but not buccal DNA in a normal 13 year
old child who was born SGA. LOM of ICR2 has been
found in blood DNA from 3/18 clinically normal chil-
dren conceived by assisted reproductive therapies [11].
Two out of 79 cases with suspected SRS, were found to
have LOM of ICR2, one of whom had additional LOM
of ICR1 in peripheral blood [6]. Each of these cases may
represent non-pathological variation at ICR2 observed
in blood DNA.
BWS is a heterogeneous clinical disorder [12]. Our
case born SGA had two minor clinical associations
observed in BWS: a small umbilical hernia and transient
neonatal hypoglycemia. These could represent an influ-
ence of ICR2 LOM, but it is also possible that both these
relatively common conditions occurred by chance alone.The incidence of transient hypoglycemia in those born
SGA is estimated at 25% [13] and umbilical hernia
at 4.1% of Caucasian babies born at term [14]. Our
case did not meet generally accepted criteria for clinical
diagnosis of BWS based on 2–3 major findings (pre-/
postnatal overgrowth, macroglossia, abdominal wall
defects, anterior ear lobe creases and/or posterior helical
pits, visceromegaly, childhood embryonal tumor, hemi-
hyperplasia, renal abnormalities, positive family history
of BWS, cleft palate) [12]. In contrast to the macrosomia
at birth and rapid early childhood growth seen in BWS,
our case was born SGA, and her height remained at
the lower 25 percentile range until the age of 13 years.
The prevalence of LOM at ICR2 in those with minimal
clinical features of BWS such as umbilical hernia
and transient neonatal hypoglycemia has not previously
been reported.
The most likely explanation for the discordant epigen-
etic result observed in leucocyte derived DNA but not
buccal DNA is that she is the surviving MZ twin of a
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weight [15]. The incidence of monozygotic twinning in
BWS is tenfold higher than population levels, and they
are almost exclusively female [16]. Loss of one twin
occurs in up to 30% of twin pregnancies conceived by
assisted reproductive techniques [17,18], and may not be
detected in most normally conceived cases due to lack
of early ultrasound detection of twin pregnancies and
complete reabsorption. Abnormal epigenetic results in
leucocyte DNA, but not buccal DNA, have been
described in the normal monozygotic twin of probands
with BWS or SRS [4,19]. In this setting, fetal sharing of
hematopoietic cells circulation in MZ monochorionic
twins [16] or the migration of blood cell precursor cells
from the common yolk sac [19] has been proposed.
Similar to our case who was healthy other than SGA,
transient neonatal hypoglycemia and umbilical hernia,
other cases of the healthy MZ twin of BWS cases have
also shown some signs of BWS such as macrosomia,
abdominal wall defects, and transient neonatal hypo-
glycemia [19-21]. The BWS features present in less
affected twins may be explained by a low level of
mosaicism in certain tissues of these individuals (in which
case the number of aberrant cells in buccal swabs are sim-
ply too low to be detected) or that these features are
caused by altered expression in the circulation of genes
controlled by ICR2 (and that the only cells with the
methylation defect in these individuals are in the circula-
tion). The high rate of LOM of ICR2 observed in the
blood may reflect the selective growth advantage for
hematopoietic cells having this defect, whereas, studies in
fibroblasts of discordant BWS twins has always only
shown the epigenetic change only in the affected twin,
favoring the latter explanation[19].
Conclusion
Our naturally-conceived girl born small for gestational
age adds to the clinical spectrum reported for LOM of
ICR2 associated with BWS, observed in leucocyte but
not buccal DNA.
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